KBC Group NV Has $387.71 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

KBC Group NV boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 992,242 shares of the healthcare conglomerate’s stock after purchasing an additional 23,848 shares during the quarter. UnitedHealth Group accounts for approximately 1.4% of KBC Group NV’s holdings, making the stock its 7th biggest position. KBC Group NV’s holdings in UnitedHealth Group were worth $387,709,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Atom Investors LP acquired a new stake in shares of UnitedHealth Group during the 2nd quarter worth about $1,723,000. Kestra Private Wealth Services LLC boosted its stake in shares of UnitedHealth Group by 13.4% in the 3rd quarter. Kestra Private Wealth Services LLC now owns 13,177 shares of the healthcare conglomerate’s stock valued at $5,149,000 after purchasing an additional 1,552 shares during the last quarter. Schmidt P J Investment Management Inc. boosted its stake in UnitedHealth Group by 0.9% during the 3rd quarter. Schmidt P J Investment Management Inc. now owns 27,320 shares of the healthcare conglomerate’s stock worth $12,421,000 after acquiring an additional 249 shares during the last quarter. Parametric Portfolio Associates LLC boosted its stake in UnitedHealth Group by 2.2% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,874,820 shares of the healthcare conglomerate’s stock worth $1,551,633,000 after acquiring an additional 81,995 shares during the last quarter. Finally, Stonebridge Capital Advisors LLC raised its holdings in UnitedHealth Group by 1.8% during the 2nd quarter. Stonebridge Capital Advisors LLC now owns 18,915 shares of the healthcare conglomerate’s stock worth $7,574,000 after buying an additional 328 shares during the period. Institutional investors own 86.10% of the company’s stock.

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 75,000 shares of the company’s stock in a transaction dated Monday, October 25th. The stock was sold at an average price of $448.72, for a total value of $33,654,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction dated Tuesday, November 23rd. The stock was sold at an average price of $444.70, for a total value of $1,111,750.00. The disclosure for this sale can be found here. 0.55% of the stock is currently owned by corporate insiders.

A number of analysts have recently issued reports on UNH shares. Oppenheimer lifted their price objective on shares of UnitedHealth Group from $465.00 to $475.00 and gave the company an “outperform” rating in a report on Friday, October 15th. SVB Leerink initiated coverage on shares of UnitedHealth Group in a research report on Monday, September 27th. They set an “outperform” rating and a $480.00 price objective for the company. Royal Bank of Canada boosted their target price on shares of UnitedHealth Group from $476.00 to $512.00 and gave the company an “outperform” rating in a research report on Wednesday, December 1st. Credit Suisse Group boosted their target price on shares of UnitedHealth Group from $462.00 to $495.00 and gave the company an “outperform” rating in a research report on Friday, October 15th. Finally, BMO Capital Markets boosted their target price on UnitedHealth Group from $475.00 to $500.00 and gave the stock a “market perform” rating in a research note on Thursday, December 2nd. They noted that the move was a valuation call. Two equities research analysts have rated the stock with a hold rating, twenty-two have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $500.54.

UnitedHealth Group stock traded down $3.67 during mid-day trading on Thursday, reaching $470.05. 37,268 shares of the stock traded hands, compared to its average volume of 3,128,163. The stock has a market capitalization of $442.72 billion, a PE ratio of 29.39, a price-to-earnings-growth ratio of 1.51 and a beta of 0.86. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.77 and a quick ratio of 0.77. UnitedHealth Group Incorporated has a 12-month low of $320.35 and a 12-month high of $509.23. The business’s 50-day moving average is $469.64 and its 200-day moving average is $435.49.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 EPS for the quarter, beating analysts’ consensus estimates of $4.41 by $0.11. The company had revenue of $72.34 billion during the quarter, compared to analysts’ expectations of $71.24 billion. UnitedHealth Group had a return on equity of 23.08% and a net margin of 5.52%. UnitedHealth Group’s revenue for the quarter was up 11.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.51 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post 18.84 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 14th. Investors of record on Monday, December 6th were given a dividend of $1.45 per share. This represents a $5.80 dividend on an annualized basis and a yield of 1.23%. The ex-dividend date was Friday, December 3rd. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.98%.

UnitedHealth Group Company Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

See Also: Net Margin – Understanding the Different Kinds of Profit

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.